AzTrials
AzTrials

Adult Spinal DeformityNCT04888104

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

An observational study of Adult Spinal Deformity and Scoliosis, run by International Spine Study Group Foundation at 9 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Adult Spinal Deformity, Scoliosis, Kyphosis
What is being tested?
Index or revision spine surgery for complex adult spinal deformity
Type of treatment
Surgery or procedure
How many people
225 participants
Where
9 sitesUnited States
Study dates
9 Jul 2021to 31 Dec 2034
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Multicenter, prospective, observational, study evaluating the safety and performance of the VersaTie System by comparing adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System

Who may be able to join

  • >18 years of age at the time of treatment
  • EOS full body or standing 36" AP \& Lateral images of entire spine
  • Posterior spine fusion with pedicle screw fixation construct of 5 or more levels
  • Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system
  • Upper instrumented vertebra (UIV) terminating at a newly instrumented level
  • Lowest instrumented vertebra (LIV) sacrum/pelvis
  • Surgery scheduled to take place in the next 6 months

Who cannot join

  • Active spine tumor or infection
  • Deformity due to acute trauma
  • Prisoners
  • Women who are pregnant
  • Patient is unwilling or unable to complete questionnaires

Trial locations and contacts

9 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Christine Baldus, MH contact

6184444130

baldusc@wustl.edu

Ray Pinteric contact

ray.pinteric@outlook.com

9 sites in 1 country

United States9 sites, 8 recruiting
  • University at Buffalo, Department of Neurosurgery

    Buffalo, New York, 14260-1660

    Nicole Armstrong, narmstrong@ubns.com

    Jeffrey Mullin, MD

    Recruiting
  • University of Virginia

    Charlottesville, Virginia, 22908

    Lorrie Sipe, 434-924-8875, lag3k@virginia.edu

    Justin Smith, MD

    Recruiting
  • Presbyterian/St. Luke's Medical Center

    Denver, Colorado, 80218

    Bret Line, breton.line@gmail.com

    Shay Bess

    Recruiting
  • Duke University Health System

    Durham, North Carolina, 27708

    Ronald Pegues, ronald.pegues@duke.edu

    Christopher I Shaffrey, MD

    Not yet recruiting
  • Shiley Center for Orthopaedic Research and Education at Scripps Clinic

    La Jolla, California, 92037

    Paulina de la Garza, 858-554-7124, delaGarza.Paulina@scrippshealth.org

    Gregory Mundis, MD

    Recruiting
  • New York University, Department of Orthopedic Surgery

    New York, New York, 10003

    Connie Maglaras, constance.maglaras@nyulangone.org

    Themistocles Protopsaltis, MD

    Recruiting
  • Barrow Neurological Institute

    Phoenix, Arizona, 85013

    Caleb Fisher, caleb.fisher900@commonspirit.org

    Jay Turner, MD

    Recruiting
  • University of California - San Francisco

    San Francisco, California, 94143

    Withdrawn
  • Louisiana Spine Institute

    Shreveport, Louisiana, 71101

    Cody McConnell, CMcConnell@louisianaspine.org

    Pierce Nunley, MD

    Recruiting

Other trials in United States

About this study

Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Read the detailed description

Specific Aims:

  • Evaluate the safety and performance of posterior spinal fusion constructs supplemented with posterior spinolaminar fixation using the VersaTie System compared to posterior fixation constructs without VersaTie System supplementation in adult patients undergoing long posterior spinal fusion by evaluating intraoperative and postoperative complications, clinical and radiographic outcomes, patient-reported outcomes (PROs) and need for revision surgery.
  • Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery.
  • Develop and validate a standardized, universal complications classification system for spine surgery
  • Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for adult spinal deformity surgery
  • Assess impact of opioid use and pain management on patient cost, complications and outcomes
  • Evaluate optimal opioid and analgesic usage and protocols for standard work development
  • Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including modified Oswestry Disability Index (mODI), Scoliosis Research Society Questionnaire 22r (SRS-22r), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS) and compare the results of these legacy PROMs to outcomes scores as measured by the NIH Patient Reported Outcomes Measurement Information System (PROMIS) - PROMIS Anxiety, Depression, Pain Interference, Physical Function, and Social Satisfaction. Secondary aims for PROM research for this study include
  1. Validation of the PROMIS tool for ASD
  2. Establish a core set of PROMs for best practice guidelines for ASD
  3. Evaluate patient reported outcome variance for ASD according to SRS-Schwab spine deformity type including variance in baseline PROM domains impacted and variance in improvement in PROM domains
  4. Evaluate ASD outcomes compared to population norms and investigate/develop appropriate measures of clinically significant improvement
  • Evaluate clinical outcomes stratifying by patient chronological and physiological age
  • Evaluate measures to quantify patient physiological age including patient frailty for ASD and validate a frailty measurement system for ASD
  • Evaluate the role of functional tests in patient's baseline frailty assessment including hand manometer and Edmonton Frail Scale. See appendix, pages 17 \& 18 for details.
  • Evaluate the contribution of patient frailty to patient outcomes, complications, cost of care, disability, and complications
  • Evaluate if patient frailty is a static measure or if frailty is a dynamic measure that can be improved through "pre-habilitation" and if the according associations with reductions in frailty correlate with reductions of cost, complications, and improvement in outcomes
  • Evaluate cost variance for ASD surgery according to patient, institution, and geographical region and evaluate the cost effectiveness of surgical intervention for ASD
  • Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients and establish best practice guidelines for assessing MH for ASD patients
  • Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for ASD surgery
  • Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for ASD surgery and risk factors for routine (home) discharge vs. skilled nursing facility (SNF)/rehabilitation facility
  • Broaden the evaluation of the surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications
  • Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for surgical treatment of ASD
  • Develop predictive analytic algorithms to risk stratify for best/worst outcomes, complications, sentinel events, and economic loss for ASD surgery
  • Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.
Being tested
Index or revision spine surgery for complex adult spinal deformity
Keywords
Scoliosis, Kyphosis, Sagittal Imbalance
Medical subject headings
Scoliosis, Kyphosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Index or revision spine surgery for complex adult spinal deformityProcedure or surgery

    Also called VersaTie System

    Adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System.

Study groups in NCT04888104
Study groupRoleWhat they receive
VersaTieNot described
Receives: Procedure: Index or revision spine surgery for complex adult spinal deformity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Scoliosis Research Society (SRS) 22r

    Scoliosis specific patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  2. Oswestry

    Spine specific patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  3. Veterans RAND 12 Item Health Survey (VR-12)

    Patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  4. Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety

    Patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  5. Patient-Reported Outcome Measurement Information System (PROMIS) - Depression

    Patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  6. Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference

    Patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  7. Patient-Reported Outcome Measurement Information System (PROMIS) - Physical Function

    Patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  8. Patient-Reported Outcome Measurement Information System (PROMIS) - Social Satisfaction

    Patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  9. Patient-Reported Outcome Measurement Information System (PROMIS) - Social Role

    Patient reported outcome

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  10. Visual Analog Scale - Back Pain

    Self-reported back pain on scale of 0 (No pain) to 10 (severe pain)

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  11. Visual Analog Scale - Leg Pain

    Self-reported leg pain on scale of 0 (No pain) to 10 (severe pain)

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

Secondary outcomes (3)
  1. Edmonton Frail Scale

    Evaluate frailty on scale of 0 to 17 where higher scores mean more frail

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  2. Canadian Study of Health and Aging (CSHA)

    Frailty scale of 1 to 9; higher scores mean more frail

    Measured: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

  3. Adverse Events

    Occurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study

    [Time Frame: 3 months and 1, 2, 5 \& 10 year post treatment]

    Measured: 3 months and 1, 2, 5 & 10 year post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2021
  2. Study start9 Jul 2021
  3. Primary completion31 Dec 2031 (estimated)
  4. Study completion31 Dec 2034 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
225 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04888104
Sponsor's protocol ID
2139
Status last verified
Feb 2026
First submitted
11 May 2021
Last updated
17 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Adult Spinal Deformity and Scoliosis, run by International Spine Study Group Foundation at 9 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christine Baldus, MH (6184444130, baldusc@wustl.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Scoliosis Research Society (SRS) 22r (time frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in